Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from GlaxoSmithKline and Sanofi Genzyme.

Cancer Summaries and Commentaries: Updates in the Treatment of Multiple Myeloma from Chicago and Frankfurt

Release Date: September 15, 2020
Expiration Date: September 15, 2021

Activity Overview

This online activity is designed to update clinicians on data presented at the 2020 ASCO Annual Meeting, held May 29-31, 2020, and at the 25th European Hematology Association (EHA25) Congress, held June 11-21, 2020, and to help facilitate critical assessment and clinical integration of new evidence. The activity reviews four abstracts that focus on multiple myeloma. For each abstract, a text summary of key clinical data is accompanied by perspectives from expert thought leaders who provide insights into how clinicians can apply these findings to their clinical practice to improve patient care.

Acknowledgment of Commercial Support

This activity is supported by educational grants from GlaxoSmithKline and Sanofi Genzyme.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This educational activity is directed toward hematologists and medical oncologists who treat patients with multiple myeloma (MM). Nurse practitioners, nurses, and fellows who treat patients with hematologic malignancies, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of MM will be invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Outline novel treatment options for patients with multiple myeloma, including targeted therapies, immunotherapies, and combination strategies
  • Explain the study design, rationale, and results of recent clinical trials evaluating novel strategies for the treatment of multiple myeloma
  • Discuss best practices to apply novel treatment strategies for the management of patients with multiple myeloma

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Thomas Martin, MD
Thomas Martin, MD
Interim Chief, Hematology
Director, Bone Marrow Transplantation
University of California, San Francisco Helen Diller Family Comprehensive Cancer Center
San Francisco, CA


Disclosures: Grant/Research Support: Sanofi, Amgen, Janssen, Seattle Genetics; Consultant: GSK.

Sagar Lonial, MD, FACP
Sagar Lonial, MD, FACP
Chair and Professor
Department of Hematology & Medical Oncology
Emory School of Medicine
Chief Medical Officer
Winship Cancer Institute of Emory University
Atlanta, GA

Disclosures: Grant/Research Support: Takeda, BMS, Celgene, Janssen; Consultant: Celgene, Takeda, Novartis, BMS, Amgen, GSK, Merck, Abbvie, Genentech; Stock/Shareholder: TG Therapeutics.

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By